Press Releases - 2023-06-16

Date	Title	Company
16-Jun-2023	Stereotactic Planning Software Spending Analysis Market valuation is expected to reach US$ 128.2 Million by 2031 \| Get Insights FMI	MARKITWIRED
16-Jun-2023	Ophthalmic Eye Drops Market is estimated to be valued at US$ 16.21 Billion in 2023	MARKITWIRED
16-Jun-2023	Value-Based Healthcare Services Market is expected to reach a valuation of US$ 20.5 Billion by 2033	MARKITWIRED
16-Jun-2023	Centrifugal Blood Pump Market is likely to expand at a 4.0% value CAGR by 2033	MARKITWIRED
16-Jun-2023	Fiducial Markers Market to reach a valuation of ~US$ 408.3 Million by the year 2033	MARKITWIRED
16-Jun-2023	Intrauterine Insemination Devices Market is expected to be valued at US$ 40.5 Million in 2023	MARKITWIRED
16-Jun-2023	RELIEF THERAPEUTICS Holding SA Announces CHF 5 Million Private Placement	Relief Therapeutics Holding SA
16-Jun-2023	Takeda und HUTCHMED geben die Genehmigung des Zulassungsantrags für Fruquintinib zur Behandlung von metastasierendem Dickdarmkrebs durch die Europäische Arzneimittelagentur bekannt	Businesswire
16-Jun-2023	U.S. Food and Drug Administration Approves Addition of Positive Data from Phase 3 VALOR-HCM Study to CAMZYOS® (mavacamten) Label	Businesswire
16-Jun-2023	Takeda and HUTCHMED Announce Publication of Phase 3 FRESCO-2 Results in The Lancet	Businesswire